Efficacy of Oritavancin in a Murine Model of Bacillus anthracis Spore Inhalation Anthrax

The inhaled form of Bacillus anthracis infection may be fatal to humans. The current standard of care for inhalational anthrax postexposure prophylaxis is ciprofloxacin therapy twice daily for 60 days. The potent in vitro activity of oritavancin, a semisynthetic lipoglycopeptide, against B. anthraci...

Full description

Saved in:
Bibliographic Details
Main Authors: Heine, H. S., Bassett, J., Miller, L., Bassett, A., Ivins, B. E., Lehoux, D., Arhin, F. F., Parr, T. R., Moeck, G.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology (ASM) 2008
Subjects:
Experimental Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533456/
https://ncbi.nlm.nih.gov/pubmed/18606841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00360-08
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items